Patents
More topics under "A61P - Specific therapeutic activity of chemical compounds or medicinal preparations" (2,008,710)
A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
A61P 11 - Drugs for disorders of the respiratory system (87,767)
A61P 13 - Drugs for disorders of the urinary system (56,135)
A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
A61P 17 - Drugs for dermatological disorders (106,455)
A61P 19 - Drugs for skeletal disorders (81,981)
A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287)
A61P 23 - Anaesthetics (4,141)
A61P 25 - Drugs for disorders of the nervous system (183,225)
A61P 27 - Drugs for disorders of the senses (53,017)
A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
A61P 3 - Drugs for disorders of the metabolism (129,789)
A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
A61P 33 - Antiparasitic agents (21,787)
A61P 35 - Antineoplastic agents (221,099)
A61P 37 - Drugs for immunological or allergic disorders (117,141)
A61P 39 - General protective or antinoxious agents (19,019)
A61P 41 - Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution (3,707)
A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
A61P 5 - Drugs for disorders of the endocrine system (28,908)
A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
Patents for A61P - Specific therapeutic activity of chemical compounds or medicinal preparations (3,181)
01/2005
01/27/2005WO2005006899A1 Treatment of male sexual dysfunction
01/27/2005US20050020635 C7 carbamoyloxy substituted taxane compositions
01/27/2005US20050020500 Glycosaminoglycan-polypeptide complex; antiarthritic agents
01/27/2005CA2533177A1 Treatment of male sexual dysfunction
01/26/2005EP1499589A1 Derivatives of n-phenyl(piperidin-2-yl)methyl benzamide, the preparation method thereof and application of same in therapeutics
01/26/2005CN1571770A Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same
01/26/2005CN1571675A Treatment and diagnosis of insulin-resistant states
01/26/2005CN1571670A Treating sexual desire disorders with flibanserin
01/26/2005CN1571658A Pharmaceutical formulation comprising (R)-bicalutamide
01/26/2005CN1186340C C10 carbonate substituted taxanes as antitumor agents
01/20/2005WO2005004989A2 Film comprising therapeutic agents
01/20/2005WO2005004988A2 Compositions and methods relating to novel compounds and targets thereof
01/20/2005US20050014795 Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same
01/20/2005US20050014788 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5)
01/20/2005US20050014766 Use of n-(indolecarbonyl-)piperazine derivatives
01/20/2005CA2530843A1 Film comprising therapeutic agents
01/19/2005EP1497266A2 Quinoline derivatives and their use as 5-ht6 ligands
01/19/2005EP1272199B1 Combination therapies with vascular damaging activity
01/19/2005CN1568207A 2-amino-6-(2, 4, 5-substituted-phenyl)-pyridines
01/19/2005CN1568183A Citalopram for the treatment of elevated blood pressure
01/13/2005US20050009920 Taxol enhancer compounds
01/13/2005US20050009150 Humanized antibodies that recognize beta amyloid peptide
01/12/2005CN1564683A Methods for treating dry eye by a combination of an antiinflammatory steroid and a MUC-1 secretagogue
01/12/2005CN1184208C Substituted benzimidazoles and their prepn. and use
01/11/2005US6840244 Condom with an erectogenic composition
01/06/2005WO2005000405A2 P38 kinase inhibitor compositions and methods of use
01/06/2005WO2005000404A2 Heterocyclic compounds for preventing and treating disorders associated with excessive bone loss
01/06/2005WO2005000403A2 Compositions and methods for treating and preventing heart tissue degeneration, and uses thereof
01/06/2005WO2005000402A2 Anti-adhesion composites and methods os use thereof
01/06/2005WO2003042177A8 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5)
01/06/2005US20050004204 2-Iminopyrrolidine derivatives
01/06/2005US20050004197 Thrombin receptors antagonists; oral efficacy
01/06/2005US20050004120 Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents
01/06/2005US20050004099 Spiroazabicyclic heterocyclic compounds
01/06/2005CA2839032A1 Compositions and methods for treating and preventing heart tissue degeneration, and uses thereof
01/06/2005CA2535980A1 P38 kinase inhibitor compositions and methods of use
01/06/2005CA2527079A1 Heterocyclic compounds for preventing and treating disorders associated with excessive bone loss
01/06/2005CA2526490A1 Compositions and methods for treating and preventing heart tissue degeneration, and uses thereof
01/06/2005CA2525788A1 Anti-adhesion composites and methods of use thereof
01/05/2005EP1109537B1 Immediate release oral formulation comprising peptide thrombin inhibitors and a combination of microcrystalline cellulose and sodium starch glycollate
01/05/2005CN1183128C N-(heterocyclic)-benzene or pyridine sulphozmides as antithrombotic agents and anticoagulants
12/2004
12/29/2004WO2003045392A8 Use of n-(indolcarbonyl-)piperazine derivatives
12/29/2004EP1490361A1 Polycyclic compounds as potent alpha2-adrenoceptor antagonists
12/29/2004EP1490049A1 Citalopram for the treatment of elevated blood pressure
12/29/2004CN1181886C Application of TNF-derived peptides in the treatment of oedema
12/23/2004US20040258777 Aqueous topical solutions stimulate endothelial growth factors and microcirculation; solvent extraction with volatile non-aqueous solvents; obestity; reduction of cellulite and localized dermal adipose deposits
12/23/2004US20040258739 Plaster for the treatment of dysfunctions and disorders of nails
12/22/2004CN1556805A Piperidine derivative as NMDA receptor antagonist
12/16/2004WO2004108728A1 Cannabinoid receptor ligands and uses thereof
12/16/2004US20040254376 Cyclic amidine derivative
12/16/2004CA2525752A1 Cannabinoid receptor ligands and uses thereof
12/15/2004EP1226137B8 Phenyl- and pyridyl-tetrahydro-pyridines having tnf inhibiting activity
12/15/2004CN1555259A use of substituted aminomethyl chromans for the treatment of movement disorders and of adverse effects induced by drugs administered to treat extrapyramidal movement disorders
12/15/2004CN1179753C Contraceptive compositions containing antiprogesting and progestinic
12/14/2004US6830765 Extract of green tea containing from 20% to 50% by mass of catechols expressed as epigallocatechol gallate
12/09/2004US20040248936 such as (R)-1-{4-[4-(4-Phenoxy-2-propyl-phenoxy)-butoxy]-benzenesulfonyl}-azetidine-2-carboxylic acid, used as peroxisome proliferator-activated receptor agonists; hypoglycemic agents
12/09/2004US20040248902 Central nervous system, gastrointestinal and psycological disorders; such as 3-(4-chlorobenzenesulfonyl)-2-methyl-7-piperazin-1-yl-1H-indole; synthesis
12/09/2004US20040248881 such as 1-[2-(2-chloro-phenyl)-3-(4-fluoro-phenyl)-2H-pyrazolo[3,4-d]pyridazin-7-yl]-4-isopropylamino-piperidine-4-carboxylic acid amide; for treatment of eating disorders and psychological disorders
12/09/2004US20040248848 Use of specific dose of fondaparinux sodium for the treatment of acs
12/08/2004EP1220856B1 Pyrazolo[4,3-d]pyrimidine derivatives
12/08/2004CN1553895A Taxol enhancer compounds
12/08/2004CN1553894A Taxol enhancer compounds
12/08/2004CN1553801A Inhalation compositions comprising tricyclic 5,6-dihydro-9H-pyrazolo (3,4-C)-1,2,4-triazolo (4,3-alpha) pyridines
12/08/2004CN1178652C Mizoribine tablet with improved colour
12/02/2004WO2004104007A1 Pyrazolo-quinazoline derivatives,process for their preparation and their use as kinase inhibitors
12/02/2004US20040242627 2-Iminoimidazole derivatives (1)
12/02/2004US20040242617 Combination of selected opioids with muscarine antagonists for treating urinary incontinence
12/02/2004US20040242606 Anti-cancer cyclopenta (g)quinazoline compounds
12/02/2004US20040242597 Combination
12/02/2004US20040242578 Pyrimidineamines as angiogenesis modulators
12/02/2004US20040242536 controlled-release mixtures of plant extracts, gelation polymers and drugs such as ximelagatran, used for prophylaxis of cardiovascular disorders
12/01/2004EP1481992A2 Humanized antibodies that sequester amyloid beta peptide
12/01/2004EP1480975A2 Chemical compounds
12/01/2004EP1480948A1 Semicarbazide derivatives and their use as antithrombotics
12/01/2004EP1257584B9 Humanized antibodies that sequester amyloid beta peptide
12/01/2004CN1551885A Cyclic indole and heteroindole derivatives, the production and use thereof as medicaments
12/01/2004CN1551872A Biologically active methylene blue derivatives
12/01/2004CN1551767A Cancer treatment
11/2004
11/25/2004WO2004101071A2 Infusion hub assembly and inserter
11/25/2004US20040235920 Novel use of substituted aminomethyl chromans for the treatment of movement disorders and of adverse effects induced by drugs administered to treat extrapyramidal movement disorders
11/25/2004US20040235909 substituted bis/thiohydrazide amide compound; synergistic effect with taxol or taxotere, anticancer agents, side effect reduction
11/25/2004US20040235894 N-[[4-(2-Chloro-4-fluorophenoxy)[1,4'-bipiperidin]-1'-yl]carbonyl]-4-methyl benzenesulfonamide, used for prophylaxis of asthma and/or rhinitis; respiratory system disorders
11/24/2004EP1478366A1 Pharmaceutical combinations of cox-2 inhibitors and opiates
11/24/2004CN1549813A Pyrimidineamines as angiogenesis modulators
11/24/2004CN1549812A Pyrazole compounds useful as protein kinase inhibitors.
11/18/2004US20040229923 Mixing a racemic mixture of enantiomers of pyrrolo[2,3-d]pyrimidine compounds in a solvent, with a resolving compound having a defined stereospecificity, to form a solution and with resolving agent being capable of binding with enantiomers to form a precipitate collecting precipitate and purifying
11/18/2004US20040229790 Substance having an activity which modulates or inhibits proliferation of AILIM(activation inducible lymphocyte immunomodulatory molecule)-expressing cells or production of a cytokine; for treatment of rheumatoid arthritis, osteoarthritis
11/18/2004DE10297331T5 Behandlung und Diagnose von Insulin-resistenten Zuständen Treatment and diagnosis of insulin-resistant conditions
11/17/2004EP1476471A1 Nutraceuticals for the treatment, protection and restoration of connective tissues
11/17/2004EP1476162A1 Controlled synthesis of ziprasidone and compositions thereof
11/17/2004EP1272468B1 Indolin-2-one derivatives, preparation and their use as ocytocin receptor ligands
11/17/2004EP1185274B1 Drug combinations comprising (e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3r,5s)-3,5-dihydroxyhept-6-enoic acid and an inhibitor, inducer or substrate of p450 isoenzyme 3a4
11/17/2004CN1547474A Skin-permeable selective cyclooxygenase-2 inhibitor composition
11/16/2004US6818672 Treating endometriosis or infertility, or improving fertility
11/11/2004US20040225139 a 3-oxo-androstrane carbothioic acid compound
11/11/2004US20040224961 Novel thiazolo (4,5-D) pyrimidine compounds
11/11/2004US20040224934 3 -oxo-androstrane carbothioic acid compound
11/11/2004US20040224931 3-oxo-androstrane carbothioic acid compound
11/10/2004EP1474395A1 Nicotinamide derivates useful as p38 inhibitors
11/10/2004EP1474117A1 Composition for inhalation
1 ... 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 ... 32